Edison Investment Research has terminated coverage on Argent Biopharma (RGT). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.
Healthcare |
Update
Healthcare |
QuickView
Healthcare |
Update
Healthcare |
Update
Igor Bluvstein
CFO
Roby Zomer
Managing Director and Co-CEO
Yifat Steuer
COO
thematic
Consumer
thematic
Energy & Resources